IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD 564.53
+21.75 (4.01%)
At close: Jul 25, 2025
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of 33.99 billion as of July 29, 2025. Its market cap has increased by 8.97% in one year.
Market Cap
33.99B
Enterprise Value
34.65B
Revenue
3.04B
Ranking
n/a
PE Ratio
49.06
Stock Price
564.53
Market Cap Chart
Since June 21, 1991, IDEXX Laboratories's market cap has increased from 42.95M to 33.99B, an increase of 79,021.00%. That is a compound annual growth rate of 21.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2025 | 33.99B | 25.68% |
| Dec 31, 2024 | 27.04B | -25.28% |
| Dec 29, 2023 | 36.19B | 29.06% |
| Dec 30, 2022 | 28.04B | -32.00% |
| Dec 31, 2021 | 41.23B | 32.03% |
| Dec 31, 2020 | 31.23B | 84.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.32B |
| GSK plc | 56.21B |
| Haleon | 32.70B |
| Smith & Nephew | 10.25B |
| ConvaTec Group | 4.88B |
| Hikma Pharmaceuticals | 4.42B |
| HUTCHMED (China) | 2.25B |
| Oxford Nanopore Technologies | 2.04B |